QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Arq (NASDAQ:ARQ) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.02) by 194.1...

Core News & Articles

Canaccord Genuity analyst George Gianarikas maintains Arq (NASDAQ:ARQ) with a Buy and raises the price target from $8 to $10.

Core News & Articles

Key achievement in ongoing corporate transformationFirst GAC sales have been completedArq well positioned to meet strong GAC ma...

Core News & Articles

Key achievement in ongoing corporate transformationFirst GAC sales have been completedArq well positioned to meet strong GAC ma...

Core News & Articles

Canaccord Genuity analyst George Gianarikas maintains Arq (NASDAQ:ARQ) with a Buy and lowers the price target from $9 to $8.

Core News & Articles

Arq (NASDAQ:ARQ) reported quarterly sales of $27.25 million which beat the analyst consensus estimate of $26.27 million by 3.73...

Core News & Articles
An Overview of Arq's Earnings
05/06/2025 18:03:52

Core News & Articles

Arq (NASDAQ:ARQ) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 pe...

Core News & Articles

Canaccord Genuity analyst George Gianarikas maintains Arq (NASDAQ:ARQ) with a Buy and lowers the price target from $10 to $9.

Core News & Articles

Canaccord Genuity analyst George Gianarikas initiates coverage on Arq (NASDAQ:ARQ) with a Buy rating and announces Price Tar...

Core News & Articles

Arq (NASDAQ:ARQ) reported quarterly earnings of $0.04 per share which met the analyst consensus estimate. The company reported...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION